Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
S-3/APre-effective amendment to an S-3 filingDec 26, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 17, 2001View HTMLDownload DOCDownload PDF
S-3MEFRegistration of up to an additional 20% of securities for any offering registered on a S-3Dec 7, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B1Form of prospectus that discloses information previously omitted from the prospectusDec 7, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingDec 4, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-K/AAmendment to a previously filed 8-KNov 15, 2001View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formNov 9, 2001View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formNov 6, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 2, 2001View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 2, 2001View HTMLDownload DOCDownload PDF
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 31, 2001View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 26, 2001View HTMLDownload DOCDownload PDFDownload XLS
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 16, 2001View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventOct 10, 2001View HTMLDownload DOCDownload PDF
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisOct 2, 2001View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 11, 2001View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 6, 2001View HTMLDownload DOCDownload PDF
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisAug 23, 2001View HTMLDownload DOCDownload PDF
POS AMPost-effective amendment to an S-Type filingAug 16, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 16, 2001View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 14, 2001View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 25, 2001View HTMLDownload DOCDownload PDF
S-3/APre-effective amendment to an S-3 filingJun 19, 2001View HTMLDownload DOCDownload PDF
S-3Simplified registration formMay 21, 2001View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-35

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information